by Asmaa Javed | Sep 29, 2025 | Past Awards
[showmodule id=”101657″] Year Awarded: 2025 Amount: $60,000 Study Length: 2 years The survival of patients with ECD has improved significantly with the increasing use of targeted therapies. Certain challenges in treating ECD still remain; these challenges...
by Asmaa Javed | Jan 23, 2024 | Past Awards
[showmodule id=”47492″] Year Awarded: 2024 Amount: 50,000 USD Survival of patients affected by Erdheim-Chester disease (ECD) has substantially improved over the last decades, thanks to the increased awareness of the disease, the consequent earlier...
by Asmaa Javed | Apr 22, 2023 | Past Awards
[showmodule id=”47611″] Year Awarded: 2023 Amount: 200,000 USD in partnership with the Leukemia & Lymphoma Society Erdheim Chester Disease (ECD) is caused by mutations in the DNA of blood cells. Blood cells are formed in the bone marrow from stem...
by Asmaa Javed | Jan 23, 2023 | Past Awards
[showmodule id=”47636″] Year Awarded: 2023 Amount: 200,000 USD in partnership with the Leukemia & Lymphoma Society The prognosis of ECD has improved tremendously due to the approval of targeted therapies. However, these treatments are administered for...
by Asmaa Javed | Apr 22, 2022 | Past Awards
[showmodule id=”47572″] Year Awarded: 2022 Amount: 20,000 USD in partnership with Uplifting Athletes Dr. Jithma Abeykoon is the Senior Associate Consultant, Assistant Professor in Hematology and Medical Oncology, and Clinician Investigator in Hematology...
by Asmaa Javed | Jan 23, 2022 | Past Awards
[showmodule id=”47640″] Year Awarded: 2012 Amount: 50,000 USD Dr. Egle Kvedaraite is a Postdoctoral Fellow with the Department of Pathology and Cancer Diagnostics at the Karolinska University Hospital – Unit of Molecular Neurobiology in Stockholm, Sweden....
